Skip to Main Content
Skip Nav Destination

Issues

Journal Name Change

Vol. 1-78 (1893-1938) were published under the journal's former title Dermatologische Zeitschrift and Vol. 79-183 (1939-1991) under Dermatologica.

Dermatology 2023, Vol. 239, No. 1

Editorial

Dermatology (2023) 239 (1): 1–4. https://doi.org/10.1159/000526338

New EU restriction of tattoo inks makes chaos in the sector with wild activity and deterioration of tattoo customer safety.

Systematic Review and Meta-Analysis

Dermatology (2023) 239 (1): 5–11. https://doi.org/10.1159/000526600
Dermatology (2023) 239 (1): 12–31. https://doi.org/10.1159/000526296

Ivermectin, ivermectin-metronidazole combined therapy, TTO, IPL, and skin cleansing are promising anti-Demodex interventions.

Dermatology (2023) 239 (1): 32–44. https://doi.org/10.1159/000525870

Studies suggest a statistically significant association between CU and atopic disorders.

Research Article

Dermatology (2023) 239 (1): 45–51. https://doi.org/10.1159/000526069
Dermatology (2023) 239 (1): 52–59. https://doi.org/10.1159/000526019

Acitretin is useful for HS patients, especially if follicular phenotype or follicular occlusion is present.

Dermatology (2023) 239 (1): 60–71. https://doi.org/10.1159/000525526

The NCSTN gene mutation might cause an abnormal structure of the hair follicle.

Dermatology (2023) 239 (1): 72–80. https://doi.org/10.1159/000525987

Intravenous immunoglobulins, ixekizumab, dupilumab, and anakinra are safe treatment options for Netherton syndrome.

Outcome Measures – Research Article

Dermatology (2023) 239 (1): 81–90. https://doi.org/10.1159/000526257

Our results show that achieving VLS clearance corresponded to significant improvement in the illness-related burden.

Atopic Dermatitis – Research Article

Dermatology (2023) 239 (1): 91–98. https://doi.org/10.1159/000525901

AD patients’ disease severity, perceived stress, and symptoms/itch were affected by the pandemic and recent earthquake in Zagreb.

Wounds and Healing – Research Article

Dermatology (2023) 239 (1): 99–108. https://doi.org/10.1159/000525844

This is the first study to validate digital wound measurement tools to enable use on all body surfaces.

Skin Infections – Research Article

Dermatology (2023) 239 (1): 109–115. https://doi.org/10.1159/000526601

Intralesional immunotherapy with MMR tended to provide higher clearance and fewer AEs than PPD.

Dermatology (2023) 239 (1): 116–121. https://doi.org/10.1159/000525725

People suffering from DI are at high risk of nonattendance.

Skin Cancer – Guidelines

Dermatology (2023) 239 (1): 122–131. https://doi.org/10.1159/000526478

Identifying recurrence risk for individual lesions enables the selection of the most effective treatment modality.

Skin Cancer – Research Article

Dermatology (2023) 239 (1): 132–139. https://doi.org/10.1159/000526788
Dermatology (2023) 239 (1): 140–147. https://doi.org/10.1159/000526143

Racial differences were seen in secondary tumors arising in NS.

Dermatology (2023) 239 (1): 148–157. https://doi.org/10.1159/000525974

Assessment of frailty and life expectancy can guide physicians and patients in treatment decisions.

Dermatology (2023) 239 (1): 158–164. https://doi.org/10.1159/000525612

A multidisciplinary management of toxicity in patients with aBCC with vismodegib prolongs survival.

Dermatology (2023) 239 (1): 165–173. https://doi.org/10.1159/000525726

NAMs with previous trauma have unique clinicoprognostic characteristics.

Erratum

Dermatology (2023) 239 (1): 174. https://doi.org/10.1159/000527857
Dermatology (2023) 239 (1): 175. https://doi.org/10.1159/000526097

or Create an Account

Close Modal
Close Modal